Wireless communication apparatus
    42.
    发明申请
    Wireless communication apparatus 审中-公开
    无线通信装置

    公开(公告)号:US20070066300A1

    公开(公告)日:2007-03-22

    申请号:US11475889

    申请日:2006-06-28

    IPC分类号: H04Q7/20

    摘要: There are provided a main master station for transmitting control data by setting, as a synchronization slot, a specific transmission slot of a time division multiple access communication frame, a sub master station for transmitting the control data by setting, as a broadcast slot, a slot which does not overlap with the synchronization slot in synchronization with the main master station, and a slave station capable of communicating with the main master station and the sub master station, and the slave station waits for the control data transmitted from the sub master station in a time width decided based on a time position of the synchronization slot upon receipt of the control data from the main master station, and carries out an incoming call operation while continuously receiving the control data from either the main master station or the sub master station in an incoming call received from the other.

    摘要翻译: 提供了通过将时分多址通信帧的特定发送时隙设置为同步时隙来发送控制数据的主主站,用于通过将广播时隙设置为广播时隙来发送控制数据的子主站 与主主站同步地与同步槽不重叠的时隙,以及能够与主主站和子主站通信的从站,从站等待从主站发送的控制数据 在从主主站接收到控制数据的基础上,基于同步时隙的时间位置确定的时间宽度,并且在连续地从主主站或副主站接收控制数据的同时执行来电操作 在从另一个接收的来电中。

    Glucopyranosyloxyprazole derivatives and use thereof in medicines
    43.
    发明申请
    Glucopyranosyloxyprazole derivatives and use thereof in medicines 有权
    吡喃葡萄糖基吡唑衍生物及其在药物中的应用

    公开(公告)号:US20060035847A1

    公开(公告)日:2006-02-16

    申请号:US11247356

    申请日:2005-10-12

    IPC分类号: A61K31/7056 C07H17/02

    摘要: The present invention provides glucopyranosyloxypyrazole derivatives represented by the general formula: wherein R represents a hydrogen atom, a lower alkyl group or a group forming a prodrug; one of Q and T represents a group represented by the general formula: (wherein P represents a hydrogen atom or a group forming a prodrug), while the other represents a lower alkyl group or a halo(lower alkyl) group; R2 represents a hydrogen atom, a lower alkyl group, a lower alkoxy group, a lower alkylthio group, a halo (lower alkyl) group or a halogen atom; and with the proviso that P does not represent a hydrogen atom when R represents a hydrogen atom or a lower alkyl group, or pharmaceutically acceptable salts thereof, which exert an inhibitory activity in human SGLT2 and have an improved oral absorption, and therefore are useful as agents for the prevention or treatment of a disease associated with hyperglycemia such as diabetes, diabetic complications or obesity, and pharmaceutically acceptable salts thereof, and pharmaceutical uses thereof.

    摘要翻译: 本发明提供由以下通式表示的吡喃葡萄糖氧吡唑衍生物:其中R表示氢原子,低级烷基或形成前药的基团; Q和T之一表示由通式表示的基团:(其中P表示氢原子或形成前药的基团),而另一个表示低级烷基或卤代(低级烷基)基团; R 2表示氢原子,低级烷基,低级烷氧基,低级烷硫基,卤代(低级烷基)或卤素原子; 并且条件是当R表示氢原子或低级烷基时,P不表示氢原子,或其药学上可接受的盐,其在人SGLT2中具有抑制活性并具有改善的口服吸收,因此可用作 用于预防或治疗与高血糖相关的疾病如糖尿病,糖尿病并发症或肥胖症的药剂及其药学上可接受的盐及其药学用途。

    Message processing apparatus
    45.
    发明授权
    Message processing apparatus 失效
    消息处理装置

    公开(公告)号:US06934738B1

    公开(公告)日:2005-08-23

    申请号:US09522584

    申请日:2000-03-10

    摘要: A message processing apparatus which handles messages exchanged over a network and explicitly notifies the recipient of the importance and other information regarding each received message. Incoming messages are received by a receiver employed in the apparatus. Those messages may contain some key information as part of their attribute data, which specifies a handler program relevant to them. A key information extraction unit extracts the key information from each received message. Consulting a table that defines the relationships between handler programs and various key information, a program loading unit then loads a specific handler program relevant to the extracted key information. The recipient may cause an event related to the received message. Depending on what kind of event it is, an execution unit chooses and executes an appropriate primitive process provided as part of the handler program. When, for example, the recipient attempts to delete an unopened message, the apparatus will warn him/her by displaying a warning message on a monitor screen.

    摘要翻译: 一种消息处理设备,其处理通过网络交换的消息并且明确地通知接收者关于每个接收到的消息的重要性和其他信息。 接收到的消息由装置中采用的接收机接收。 这些消息可以包含一些关键信息作为其属性数据的一部分,其指定与它们相关的处理程序。 密钥信息提取单元从每个接收的消息中提取密钥信息。 咨询定义处理程序与各种关键信息之间关系的表,程序加载单元然后加载与提取的关键信息相关的特定处理程序。 收件人可能会导致与收到的邮件相关的事件。 根据事件的类型,执行单元选择并执行作为处理程序的一部分提供的适当的原语过程。 例如,当收件人尝试删除未打开的消息时,设备将通过在监视器屏幕上显示警告消息来警告他/她。

    Glucopyranosyloxybenzylbenzene derivatives, medicinal compositions containing the same and intermediates in the production thereof
    47.
    发明申请
    Glucopyranosyloxybenzylbenzene derivatives, medicinal compositions containing the same and intermediates in the production thereof 审中-公开
    吡喃葡萄糖氧基苄基苯衍生物,含有它们的药物组合物及其制备中间体

    公开(公告)号:US20050113315A1

    公开(公告)日:2005-05-26

    申请号:US10978331

    申请日:2004-11-02

    CPC分类号: C07H15/203

    摘要: The present invention relates to glucopyranosyloxybenzylbenzene derivatives represented by the general formula: wherein R1 represents a hydrogen atom, a hydroxy group, a substituted or unsubstituted amino group, a carbamoyl group, a substituted or unsubstituted(lower alkyl) group, a substituted or unsubstituted(lower alkoxy) group etc.; R2 represents a hydrogen atom or a lower alkyl group; and R3 represents a substituted or unsubstituted(lower alkyl) group, a substituted or unsubstituted(lower alkoxy) group, a substituted or unsubstituted(lower alkylthio) group etc., or pharmaceutically acceptable salts thereof, which have an inhibitory activity in human SGLT2 and are useful as agents for the prevention or treatment of a disease associated with hyperglycemia such as diabetes, diabetic complication or obesity, pharmaceutical compositions comprising the same and intermediates thereof.

    摘要翻译: 本发明涉及由以下通式表示的吡喃葡萄糖氧基苄基苯衍生物:其中R 1表示氢原子,羟基,取代或未取代的氨基,氨基甲酰基,取代或未取代的(低级烷基 )基团,取代或未取代的(低级烷氧基)基团等; R 2表示氢原子或低级烷基; 和R 3表示取代或未取代的(低级烷基)基团,取代或未取代的(低级烷氧基)基团,取代或未取代的(低级烷硫基)等,或其药学上可接受的盐,其中 在人SGLT2中具有抑制活性,并且可用作预防或治疗与高血糖相关的疾病如糖尿病,糖尿病并发症或肥胖症的药剂,包含其的药物组合物及其中间体。

    Problem solving operation apparatus using a state transition
    48.
    发明授权
    Problem solving operation apparatus using a state transition 失效
    使用状态转换的问题求解运算装置

    公开(公告)号:US6052678A

    公开(公告)日:2000-04-18

    申请号:US356979

    申请日:1994-12-16

    IPC分类号: G06N3/12 G06N5/00

    CPC分类号: G06N3/126 G06N5/003

    摘要: A problem solving operation apparatus obtains an optimum solution for a given problem through a combined use of a plurality of optimum solution search techniques of a genetic algorithm, and other search techniques like a hill climbing method. A combination of the optimum solution search techniques applied to each of a group of solution candidates varies according to each state. When a search efficiency in a single state is lowered, the problem solving operation apparatus immediately causes a state transition to the next state, thus enabling a search of an optimum solution through the use of another combination of more efficient optimum solution search techniques. Because a state transition constantly maintains a high search efficiency, this problem solving operation apparatus can reach an optimum solution in a short amount of time.

    摘要翻译: 问题解决操作装置通过综合使用遗传算法的多个最优解搜索技术以及诸如爬山方法的其他搜索技术来获得给定问题的最优解。 应用于一组解决方案候选者中的每一个的最佳解决方案搜索技术的组合根据每种状态而变化。 当单一状态的搜索效率降低时,问题解决操作装置立即使状态转换到下一状态,从而通过使用更有效的最优解搜索技术的另一组合来搜索最佳解。 由于状态转换始终保持较高的搜索效率,所以该问题解决操作装置可以在短时间内达到最佳解决方案。